Mirada Casebook Case study 1: Colorectal. Indication: T3 N1 R0 sigmoid colectomy August 2009 CT demonstrated solitary segment VI/VII liver metastasis.

Slides:



Advertisements
Similar presentations
The Thyroid Incidentaloma
Advertisements

Radiological Category: Case Report Submitted by:Matthew Bean MSIV Faculty reviewer:Sandra Oldham M.D Date accepted: August 28, 2014 Principal Modality.
CT SHOULDER AXIAL.
-- CTSA at RSNA 2010 PET/CT Analysis using 3D Slicer Jeffrey Yap PhD Ron Kikinis MD Wendy Plesniak PhD PET/CT Visualization and Analysis.
Introduction to PET/CT in Oncology: Practical Aspects Jeffrey T. Yap, PhD Department of Imaging Dana-Farber Cancer Institute.
Total Lesion Glycolysis by 18 F-FDG PET/CT a Reliable Predictor of Prognosis in Soft Tissue Sarcoma Ilkyu Han Musculoskeletal Tumor Center, Seoul National.
JHSGR 16 th April 2011 Dr Lee Man Kit Derek.  The value of PET in staging adenocarcinoma (e.g. colorectal cancer) is well established Tomoharu T. et.
AN INTRODUCTION TO PET-CT SCANNING Ray Murphy Chair – MCCN Partnership Group.
1 © 2015, Elsevier Inc., Heymann, Bone Cancer, Second Edition Chapter 45 DIAGNOSIS OF BONE METASTASES IN UROLOGICAL MALIGNANCIES - AN UPDATE.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Hugh M Dainer Affiliation: National Capital Consortium.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
Dual-time point 18F-FDG PET/CT scan: is it always working?
PET Applications in Oncology
Kh Taalab IMC Role of FDG PET In Characterization of Lung Diseases Cairo Chest 2014 Khalid Muhammad Taalab M.B,B.Ch., M.Sc., M.D. IAEA- Research Fellowship.
-- CTSA at RSNA 2009 PET/CT Analysis using 3D Slicer Jeffrey Yap PhD Ron Kikinis MD Wendy Plesniak PhD Slicer3 Training Compendium.
Functional Imaging with PET for Sarcoma Rodney Hicks, MD, FRACP Director, Centre for Molecular Imaging Guy Toner, MD, FRACP Director, Medical Oncology.
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
Follow up in Chest Tumors : Value of integrated PET/CT By : Dr. Heba Nabil, MSc Radiology Specialist at Nasser Institute For Research and Treatment.
Jeffrey Yap, PhD Ron Kikinis, MD Wendy Plesniak, PhD -1- CTSA at RSNA 2009 PET/CT Analysis using 3D Slicer Jeffrey Yap PhD Ron Kikinis MD Wendy Plesniak.
The Royal Marsden Solitary fibrous tumours The outcomes of 106 patients illustrating the unpredictable biological behaviour N Alexander, K Thway, JM Thomas,
Preoperative staging of hilar cholangiocarcinoma by dual-modality PET/CT. DR SIKANDAR YASHODA HOSPITALS HYDERABAD.
Date of download: 6/20/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Evaluation of Benign vs Malignant Hepatic Lesions.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnostic Accuracy of Colorectal Cancer Staging.
Badiee MD SPRING 2017 MULTIMODALITY
Multiple Myeloma: 18F-FDG-PET/CT and Diagnostic Imaging
Chronic pulmonary embolism
PET Applications in Oncology 2015/2016
CT and PET imaging in non-small cell lung cancer
PET Criteria for Response Assessment After Completion of Therapy for Aggressive NHL and HL Definition of a positive PET scan (Visual assessment is adequate,
Soft tissue sarcoma. Forty-eight-year-old morbidly obese woman with a painless rapidly enlarging left anterior thigh. (A) Lateral radiograph of the left.
Soft tissue sarcoma. Forty-eight-year-old morbidly obese woman with a painless rapidly enlarging left anterior thigh. (A) Lateral radiograph of the left.
Squamous cell carcinoma
FDG PET-CT of Genitourinary and Gynecologic Tumors: Overcoming the Challenges of Evaluating the Abdomen and Pelvis  Leslie K. Lee, MD, Aoife Kilcoyne,
Monday Physics Case of the Day Answers (1 of 3) Paul E
Hugo J.A. Adams, Rutger A.J. Nievelstein, Thomas C. Kwee  Blood Reviews 
Bone scan showing bone metastases
Positron emission tomography (PET scan)
Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer staging  Doenja M.J. Lambregts,
FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies  Marcelo F.K. Benveniste, MD, Cesar A.
A 21-Year-Old Patient With a HER2-Positive Colorectal Cancer
Figure 1 Carotid artery inflammation detected using 18F-FDG-PET
[18F] 3-deoxy-3′-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-d-glucose positron emission.
Volume 65, Issue 4, Pages (April 2014)
Volume 148, Issue 2, Pages e42-e47 (August 2015)
The Role of Modern Molecular Imaging Techniques in Gastroenterology
Nat. Rev. Urol. doi: /nrurol
Carmel G. Cronin, Michael Moore, Michael A. Blake 
Integrated positron emission tomography (PET)/computed tomography (CT)
Incidental finding of a nodular lesion in the right upper lobe
Functional imaging in liver tumours
Retrospective Review of Efficacy of Radiofrequency Ablation for Treatment of Colorectal Cancer Liver Metastases From a Canadian Perspective  Benjamin.
Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease  Geoffrey M. Graeber, MD*, Naresh.
Example of pretreatment (A and B) and 8-week posttreatment (C and D) PET CT images. Example of pretreatment (A and B) and 8-week posttreatment (C and D)
MR-PET of the body: Early experience and insights
Hilly or mountainous surface: a new CT feature to predict the behavior of pure ground glass nodules?  Andrea Borghesi, Silvia Michelini, Francesco Bertagna,
Gross tumour delineation on computed tomography and positron emission tomography- computed tomography in oesophageal cancer: A nationwide study  M.E. Nowee,
The role of positron emission tomography for non-small cell lung cancer  Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD  Practical.
Matthew Reichert, MD, Eric S. Bensadoun, MD 
Fig F-FGln shows uptake in human gliomas undergoing progression.
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer  Catherine A.B Saunders, Julian.
Evaluation of Average CT to reduce the artifact in PET/CT
B. CT bone setting finding, which corresponds to the location of the…
(A) Na18F PET images (maximum-intensity projection).
Fig. 1.Representative images of 18F-FDG PET-CT and immunohistochemical staining for TILs. (A) Whole-body 18F-FDG PET image demonstrates increased FDG uptake.
A) Chest CT showing a lobulated necrotic mass in left hilar region with foci of calcifications and spiculated ­margins at the time of diagnosis. b) PET-CT.
Representative biodistribution pattern of 111In-CMD-193.
Serial CT scan images from patient with a partial response.
Examples of imaging data in patients.
Figure 12a Pitfalls in N staging at CT and PET
Presentation transcript:

Mirada Casebook Case study 1: Colorectal

Indication: T3 N1 R0 sigmoid colectomy August 2009 CT demonstrated solitary segment VI/VII liver metastasis PET/CT 18FDG Whole Body: skull base to upper thigh. Findings Blood glucose = 5.6 mmol/l There are two definite foci of increased uptake in keeping with hepatic metastases F1: posteriorly in segment VI/VII (1.4 cm SUV max = 6.8) and F2: segment Iva (1cm SUV max = 5.1) No evidence of residual or recurrent disease at the primary tumour site. No FDG avid locoregional or distant lymph-nodes. No other PET evidence of malignancy. Case 1: 18FDG PET/CT Colorectal Restaging

How Casebook was used in this example The bookmarks in the presentation relate to the findings in the corresponding scan. During a presentation these may be discussed while showing the finding in Casebook. In the sample bookmarks we have shown some of the features of Casebook including: Bookmark 1: Shows only the base layer, illustrates the lesion in CT only Bookmark 2: Shows the same view with the PET overlay on, and the cross-hairs off Bookmark 3: Shows the same lesion, adjusting window, level, zoom and pan Bookmark 4: Demonstrates a change of colormap, view layout and overlay transparency Bookmark 5: Showing the second lesion in all views and hiding the overlay text Bookmark 6: Changes to the coronal view and adjusts the base window and level Bookmark 7: Switches to axial view, hides the cross-hairs and adjusts the overlay transparency All the navigation and image display adjustments are available during presentation. For example, if a question is asked for which a bookmark has not been prepared, you can navigate or adjust the display appropriately. Another advantage of Casebook is that you can adjust the window and level or fusion transparency to compensate for poor projection.